Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

NCX 1015

Known as: NCX-1015, NCX1015 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
BACKGROUND The cardiac sodium/calcium (Na+/Ca2+) exchanger (NCX) contributes to diastolic depolarization in cardiac pacemaker… Expand
Is this relevant?
2008
2008
BACKGROUND The addition of a nitric oxide (NO)-releasing moiety to prednisolone was shown to enhance the anti-inflammatory… Expand
Is this relevant?
2004
2004
Daily administration of prednisolone, but not the derivative NCX-1015 (or prednisolone 21-[4'-nitrooxymethyl]benzoate), to rats… Expand
  • table 1
  • figure 1
  • figure 3
  • figure 2
  • table 2
Is this relevant?
2003
2003
It has recently emerged that posttranslational modification of proteins via nitration of tyrosine residues can alter their… Expand
Is this relevant?
2003
2003
1. Derivatization of nonsteroidal anti-inflammatory drugs, such that they release nitric oxide (NO) in small amounts, has been… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2002
2002
Here, we describe the improved antiarthritic properties of a nitric oxide-releasing derivative of prednisolone that includes a… Expand
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2002
2002
NCX-1015 is a nitric oxide (NO)-releasing derivative of prednisolone. In this study we show NCX-1015 protects mice against the S… Expand
Is this relevant?
2002
2000
2000
1. Anti-inflammatory effects of a novel derivative of the glucocorticoid prednisolone were investigated. NCX-1015 (prednisolone… Expand
Is this relevant?